Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BSGM

Biosig Technologies (BSGM) Stock Price, News & Analysis

Biosig Technologies logo

About Biosig Technologies Stock (NASDAQ:BSGM)

Key Stats

Today's Range
$4.36
$6.12
50-Day Range
$3.68
$6.35
52-Week Range
$0.59
$14.11
Volume
3.10 million shs
Average Volume
1.08 million shs
Market Capitalization
$199.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biosig Technologies, Inc. is a clinical-stage medical device company developing advanced signal acquisition and processing systems for interventional electrophysiology. Its lead product, the PURE EP™ System, is designed to enhance the quality and reliability of intracardiac recordings during diagnostic and therapeutic procedures for cardiac arrhythmias, including atrial fibrillation and other rhythm disorders.

The PURE EP™ System integrates proprietary hardware and software to deliver higher-fidelity electrograms, helping physicians distinguish true cardiac signals from noise. Biosig Technologies is collaborating with electrophysiology labs and research institutions across the United States to conduct clinical studies and support regulatory filings aimed at expanding market access for its platform.

Founded in the early 2010s and headquartered in New York, Biosig Technologies has pursued U.S. Food and Drug Administration (FDA) regulatory clearance for its flagship device and initiated preparations for European CE mark registration. The company’s pipeline also includes software upgrades and ancillary tools intended to further improve procedural workflows and patient outcomes.

Under the leadership of President and Chief Executive Officer Kenneth L. Londoner, Biosig Technologies is positioning its PURE EP™ platform to address unmet needs in the growing field of cardiac rhythm management. By offering enhanced signal clarity and analytic capabilities, the company aims to become a preferred partner for electrophysiologists seeking innovative technologies to optimize interventional procedures.

AI Generated. May Contain Errors.

Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biosig Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSGM Stock News Headlines

Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance estimates it could unlock $400 trillion - but analyst Jeff Brown, who was consulted by Congressional offices on the legislation, believes the real figure could reach $2.6 quadrillion. Brown says this shift will pour onto a new type of investment exchange - and he's showing investors how to position themselves starting with just $100.tc pixel
See More Headlines

BSGM Stock Analysis - Frequently Asked Questions

Biosig Technologies, Inc. (NASDAQ:BSGM) posted its quarterly earnings results on Friday, August, 15th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.70.

Biosig Technologies's stock reverse split before market open on Friday, February 2nd 2024.The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biosig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F).

Company Calendar

Last Earnings
8/15/2025
Today
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Capital Markets
Sub-Industry
Asset Management & Custody Banks
Current Symbol
NASDAQ:BSGM
CIK
1530766
Fax
N/A
Employees
50
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.33 million
Net Margins
N/A
Pretax Margin
-201,392.33%
Return on Equity
-5,336.99%
Return on Assets
-90.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.03

Sales & Book Value

Annual Sales
$13 thousand
Price / Sales
15,334.89
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-70.50

Miscellaneous

Outstanding Shares
31,419,000
Free Float
23,627,000
Market Cap
$199.35 million
Optionable
No Data
Beta
1.82

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:BSGM) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners